Literature DB >> 10226540

Immunohistochemical localisation of tenascin in invasive ductal carcinoma of the breast.

A M Tökés1, E Hortoványi, G Csordás, J Kulka, G Mózes, A Hatalyák, A Kádár.   

Abstract

BACKGROUND: The association of TN expression, tumour grading and expression of commonly used histopathologic prognostic factors (p53 and estrogen receptor) was examined in 62 cases of invasive ductal carcinoma of the breast.
MATERIAL AND METHODS: Following histological grading immunohistochemical reactions were undertaken on routine histopathologic samples and the results semiquantitatively evaluated.
RESULTS: Strong TN expression was found in close proximity of the neoplastic epithelial cells in each case, but not in other areas of the stroma. In 10 (16%) cases TN expression was detected to the neoplastic epithelial cells as well. There was no statistically significant difference in the extent of stromal TN immunoreaction between tumours of different grades. A significant difference was found in p53 and estrogen receptor immunoreactions by tumour grade (p = 0.05). TN immunoreaction in the stroma did not correlate with the nuclear expression of p53, Ki-67 and estrogen receptor in the tumour cells.
CONCLUSIONS: TN immunoreactivity does not seem to correlate with currently used prognostic factors. The increased expression of stromal TN in invasive breast ductal carcinomas is an other indicator of possible role played by the extracelular matrix components in cancer development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10226540

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Tenascin immunoreactivity in the large bowel and the liver in patients with colorectal cancer.

Authors:  M V Gulubova; T Vlaykova
Journal:  Histochem J       Date:  2001-02

2.  Tenascin expression in primary and recurrent breast carcinomas and the effect of tenascin on breast tumor cell cultures.

Authors:  A M Tokés; S Paku; S Tóth; E Paál; J Kulka; J Tóth; A Telekes
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

3.  Clinical significance of serum tenascin-C levels in breast cancer.

Authors:  D Tastekin; F Tas; S Karabulut; D Duranyildiz; M Serilmez; M Guveli; S Vatansever
Journal:  Tumour Biol       Date:  2014-04-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.